Investigators compared the safety of SGLT2 inhibitors vs GLP-1RAs in patients with type 2 diabetes and CKD treated in routine US practice.
All articles by Natasha Persaud
A study investigated the prognostic value of the serum uric acid to HDL cholesterol ratio in chronic kidney disease (CKD).
The latest findings are from a post hoc meta-analysis of pooled data from the DAPA-HF and DELIVER trials.
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulinlike growth factor binding protein 7 (IGFBP7) could be used for AKI staging.
A round up of studies suggests it is difficult to increase serum total 25-hydroxyvitamin D levels enough to effectively lower elevated parathyroid hormone (PTH) levels in overweight patients with chronic kidney disease.
Prescribing physical activity and exercise may be a “potent tool” for clinicians caring for older adults, according to investigators.
New data from DOPPS support previous studies finding higher risk for gastrointestinal injury after use of sodium polystyrene sulfonate.
Study is the largest to explore this potential safety issue to date.
Here’s what clinicians and patients need to know.
A reduction in urinary citrate levels may be the mechanism underlying the higher incidence of kidney stones in patients taking PPIs, according to investigators.
In a study of kidney transplant recipients, PPI users had an almost 2-fold increased risk of mortality compared with nonusers.